SN-22, (4S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Irinotecan Related Compound E
IDENTITY
CAS Number:
78287-27-1
MDL Number:
MFCD06657922
MF:
C22H20N2O4
MW:
376.41
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:
>98% (HPLC)
Physical Form (at 20°C):
Solid
Melting Point:
271-274°C
Optical Rotation:
+40 - +46° (c=0.4, CHCl3:MeOH=8:2)
Long-Term Storage:
Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material
REVIEW 7-Ethylcamptothecin is an advanced intermediate in the preparation of irinotecan, a topoisomerase I inhibitor used as an anticancer drug. It has also been shown to have antitumor activity itself.
Sawada, Seigo; Nokata, Kenichiro; Furuta, Tomio; Yokokura, Teruo; Miyasaki, Tadashi Chemical modification of an antitumor alkaloid camptothecin: synthesis and antitumor activity of 7-C-substituted camptothecins Chemical & Pharmaceutical Bulletin (1991), 39(10), 2574-80.
[3]
Sawada S; Yaegashi T; Furuta T; Yokokura T; Miyasaka T Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: E-lactone ring-modified water-soluble derivatives of 7-ethylcamptothecin Chemical & pharmaceutical bulletin (1993), 41(2), 310-3.
[4]
Lin, Chien-Hsing; Cheng, Yung-Fa; Cheng, Kau-Ming Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin PCT Int. Appl. (2004), WO 2004100897 A2 20041125.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
??
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.